• Wed, May 29, 2024

by: WOPRAI

Harsh Kumar Reiterated (SMTC) at Buy with Increased Target to $60 on, May 29th, 2024

by: WOPRAI

Mike Cikos Reiterated (SNOW) at Strong Buy and Held Target at $210 on, May 29th, 2024

by: WOPRAI

Lauren Lieberman Maintained (STZ) at Buy with Decreased Target to $288 on, May 29th, 2024

by: WOPRAI

Lauren Lieberman Maintained (TAP) at Hold with Decreased Target to $55 on, May 29th, 2024

by: WOPRAI

Patrick Scholes Maintained (CCL) at Hold with Decreased Target to $17 on, May 29th, 2024

by: WOPRAI

Jonathan Keypour Maintained (CELH) at Hold with Increased Target to $84 on, May 29th, 2024

by: WOPRAI

Douglas Tsao Reiterated (TBPH) at Strong Buy and Held Target at $20 on, May 29th, 2024

by: WOPRAI

Sebastiano Petti Maintained (TDS) at Buy with Decreased Target to $34 on, May 29th, 2024

by: WOPRAI

Ronald Epstein Maintained (TDG) at Strong Buy on, May 29th, 2024

by: WOPRAI

Kannan Venkateshwar Maintained (TGI) at Buy with Decreased Target to $18 on, May 29th, 2024

by: WOPRAI

Josh Wolfson Downgraded (TFPM) to Hold and Increased Target to $19 on, May 29th, 2024

by: WOPRAI

David Karnovsky Maintained (TKO) at Buy with Increased Target to $126 on, May 29th, 2024

by: WOPRAI

Finian O"Shea Downgraded (TPVG) to Sell and Decreased Target to $8.5 on, May 29th, 2024

by: WOPRAI

Matthew Harrigan Reiterated (TMUS) at Strong Buy and Held Target at $200 on, May 29th, 2024

by: WOPRAI

Mathew Blackman Maintained (TNDM) at Strong Buy with Increased Target to $60 on, May 29th, 2024

by: WOPRAI

Sanjay Sakhrani Maintained (TOST) at Hold and Held Target at $26 on, May 29th, 2024

by: WOPRAI

Mike Matson Downgraded (SRDX) to Hold on, May 29th, 2024

by: WOPRAI

James Sidoti Downgraded (SRDX) to Hold and Held Target at $43 on, May 29th, 2024

by: WOPRAI

Brooks O"Neil Downgraded (SRDX) to Hold and Held Target at $43 on, May 29th, 2024

by: WOPRAI

Paul Fremont Maintained (SRE) at Strong Buy with Decreased Target to $79 on, May 29th, 2024

by: WOPRAI

Stephen Scouten Maintained (SSB) at Buy with Increased Target to $98 on, May 29th, 2024

by: WOPRAI

Sheila Kahyaoglu Upgraded (UAL) to Strong Buy and Increased Target to $65 on, May 29th, 2024

by: WOPRAI

Stephen Trent Maintained (UAL) at Strong Buy with Increased Target to $96 on, May 29th, 2024

by: WOPRAI

Gordon Johnson Reiterated (TSLA) at Strong Sell and Held Target at $23 on, May 29th, 2024

by: WOPRAI

Mark Altschwager Maintained (ULTA) at Buy with Decreased Target to $525 on, May 29th, 2024

by: WOPRAI

Susan Anderson Maintained (ULTA) at Strong Buy with Decreased Target to $522 on, May 29th, 2024

by: WOPRAI

Eric Beder Reiterated (UGRO) at Strong Buy and Held Target at $8 on, May 29th, 2024

by: WOPRAI

Ed Arce Reiterated (UNCY) at Strong Buy and Held Target at $4.5 on, May 29th, 2024

by: WOPRAI

Joe Vruwink Maintained (VEEV) at Buy with Increased Target to $255 on, May 29th, 2024

by: WOPRAI

Sebastiano Petti Maintained (USM) at Buy with Increased Target to $69 on, May 29th, 2024

by: WOPRAI

Anthony Powell Maintained (AMH) at Buy with Decreased Target to $42 on, May 29th, 2024

by: WOPRAI

Kevin Cassidy Maintained (AMBA) at Strong Buy and Held Target at $85 on, May 29th, 2024

by: WOPRAI

Li Watsek Reiterated (ALXO) at Buy on, May 29th, 2024

by: WOPRAI

Crispin Love Maintained (VRTS) at Buy with Increased Target to $267 on, May 29th, 2024

by: WOPRAI

Jeff Grampp Maintained (VSTM) at Strong Buy with Decreased Target to $20 on, May 29th, 2024

by: WOPRAI

Alexei Gogolev Maintained (WIX) at Hold with Increased Target to $195 on, May 29th, 2024

by: WOPRAI

Seth Basham Reiterated (WOOF) at Buy and Held Target at $4 on, May 29th, 2024

by: WOPRAI

David Manthey Downgraded (WCC) to Hold and Decreased Target to $195 on, May 29th, 2024

by: WOPRAI

John Eade Maintained (XYL) at Strong Buy with Increased Target to $165 on, May 29th, 2024

by: WOPRAI

Sheila Kahyaoglu Downgraded (AAL) to Hold and Decreased Target to $12 on, May 29th, 2024

by: WOPRAI

Andrew Didora Maintained (AAL) at Sell with Decreased Target to $11 on, May 29th, 2024

by: WOPRAI

Daniel Mckenzie Downgraded (AAL) to Hold on, May 29th, 2024

by: WOPRAI

Helane Becker Maintained (AAL) at Strong Buy with Decreased Target to $16 on, May 29th, 2024

by: WOPRAI

David Vernon Maintained (AAL) at Buy with Decreased Target to $18 on, May 29th, 2024

by: WOPRAI

Seth Basham Maintained (AAP) at Hold with Decreased Target to $65 on, May 29th, 2024

by: WOPRAI

Roger Boyd Maintained (ZS) at Strong Buy with Decreased Target to $270 on, May 29th, 2024

by: WOPRAI

Keith Bachman Maintained (ZS) at Buy with Decreased Target to $192 on, May 29th, 2024

by: WOPRAI

Joe Vruwink Maintained (ADSK) at Buy with Decreased Target to $289 on, May 29th, 2024

Douglas Tsao Reiterated (TBPH) at Strong Buy and Held Target at $20 on, May 29th, 2024

Douglas Tsao of HC Wainwright & Co., Reiterated "Theravance Biopharma, Inc." (TBPH) at Strong Buy and Held Target at $20 on, May 29th, 2024.

Douglas has made no other calls on TBPH in the last 4 months.



There is 1 other peer that has a rating on TBPH. Out of the 1 peers that are also analyzing TBPH, 0 agree with Douglas's Rating of Hold.



This is the rating of the analyst that currently disagrees with Douglas

  • Julian Harrison of "BTIG" Initiated at Strong Buy and Held Target at $21 on, Friday, April 12th, 2024